4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-22-033927
Options or other derivatives
- Chief Commercial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Francomano Robert Chief Commercial Officer | 2022-03-14 | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | D | ||
Loading xslF345X03/tm229354-1_4seq1.xml…